| # | Drug | Count |
|---|---|---|
| 0 | IBRUTINIB | 8 |
| 1 | CYCLOPHOSPHAMIDE | 6 |
| 2 | CYCLOPHOSPHAMIDE FOR INJECTION | 6 |
| 3 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 6 |
| 4 | DOXORUBICIN | 6 |
| 5 | PREDNISONE | 6 |
| 6 | RITUXIMAB | 6 |
| 7 | DOXORUBICIN HYDROCHLORIDE | 4 |
| 8 | FLUDARABINE PHOSPHATE | 4 |
| 9 | VINCRISTINE SULFATE | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TALIMOGENE LAHERPAREPVEC | 1 | 0.0006 |
| 1 | NERATINIB | 1 | 0.0004 |
| 2 | SACITUZUMAB GOVITECAN | 1 | 0.0002 |
| 3 | RAMUCIRUMAB | 1 | 0.0002 |
| 4 | VINCRISTINE SULFATE | 4 | 0.0001 |
| 5 | DOXORUBICIN HYDROCHLORIDE | 4 | 0.0001 |
| 6 | BENDAMUSTINE HYDROCHLORIDE | 1 | 0.0001 |
| 7 | SELINEXOR | 1 | 0.0001 |
| 8 | FLUDARABINE PHOSPHATE | 4 | 0.0001 |
| 9 | IBRUTINIB | 8 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 12 |
| 1 | Corticosteroid [EPC] | 7 |
| 2 | Alkylating Drug [EPC] | 6 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 6 |
| 4 | Aromatase Inhibitor [EPC] | 2 |
| 5 | Benzodiazepine [EPC] | 2 |
| 6 | Insulin Analog [EPC] | 2 |
| 7 | Interleukin-23 Antagonist [EPC] | 2 |
| 8 | Purine Antimetabolite [EPC] | 2 |
| 9 | Angiotensin 2 Receptor Blocker [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 1 | Nuclear Export Inhibitor [EPC] | 1 | 0.0001 |
| 2 | Estrogen Receptor Antagonist [EPC] | 1 | 0.0000 |
| 3 | Alkylating Drug [EPC] | 6 | 0.0000 |
| 4 | Kinase Inhibitor [EPC] | 12 | 0.0000 |
| 5 | CTLA-4-directed Blocking Antibody [EPC] | 1 | 0.0000 |
| 6 | Purine Antimetabolite [EPC] | 2 | 0.0000 |
| 7 | Interleukin-23 Antagonist [EPC] | 2 | 0.0000 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 6 | 0.0000 |
| 9 | Aromatase Inhibitor [EPC] | 2 | 0.0000 |